4 IBD IVS: Financial statements 2017
CVR: 37446939
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
4 IBD IVS (CVR 37446939) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 62,291 and a net result of DKK -39,817 compared with DKK 102,817 the year before. That is a decrease of 82.9% compared with the year before. Equity in the 2017 report amounted to DKK 11,301. The solvency ratio was 66%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 62,291
- Profit/Loss
- DKK -39,817
- Equity
- DKK 11,301
- Total Assets
- DKK 17,122
- Employees
- 1
Official annual report
Keep an eye on 4 IBD IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
4 IBD IVS has published its interim report for the period February 10, 2016 to December 31, 2016.
About 4 IBD IVS
4 IBD IVS was a Danish company of the type Iværksætterselskab based in Hvide Sande, founded in 2016. The company has been dissolved on 14 February 2019. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company has 0 employees (2017). In 2017, the company reported a gross profit of DKK 62,291 and a net result of DKK -39,817 compared with DKK 102,817 the year before. Equity in the 2017 report amounted to DKK 11,301.